MMP-9 from sublethally irradiated tumor promotes Lewis lung carcinoma cell invasiveness and pulmonary metastasis

Oncogene

Volumn 31, Issue 4, 2012, Pages 458-468

  Chou, C H ^a,b   Teng, C M ^a   Tzen, K Y ^b,c   Chang, Y C ^b   Chen, J H H ^c   Cheng, J C H ^a,b,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Invasiveness; Lewis lung carcinoma; Metastasis; MMP 9; Radiation

Indexed keywords

GELATINASE A; GELATINASE B; GREEN FLUORESCENT PROTEIN; SMALL INTERFERING RNA; ZOLEDRONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INVASION; CANCER RADIOTHERAPY; CARCINOGENICITY; CELL CYCLE ARREST; CELL INVASION; CHORIOALLANTOIS; CONTROLLED STUDY; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; IRRADIATION; LEWIS CARCINOMA; LUNG METASTASIS; LUNG PARENCHYMA; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ANIMALS; CARCINOMA, LEWIS LUNG; CHICK EMBRYO; DIPHOSPHONATES; IMIDAZOLES; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS;

MUS;

EID: 84856216331     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.240     Document Type: Article

References (29)

1. Ahn GO, Brown JM. (2008). Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell 13: 193-205. (Pubitemid 351318369)
2. Ahn GO, Brown JM. (2009). Influence of bone marrow-derived hematopoietic cells on the tumor response to radiotherapy. Cell Cycle 8: 970-976.
3. Basile DP, Fredrich K, Weihrauch D, Hattan N, Chilian WM. (2004). Angiostatin and matrix metalloprotease expression following ischemic acute renal failure. Am J Physiol Renal Physiol 286: F893-F902. (Pubitemid 38508990)
4. Bernhard EJ, Gruber SB, Muschel RJ. (1994). Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc Natl Acad Sci USA 91: 4293-4297. (Pubitemid 24143419)
5. Bode W, Maskos K. (2003). Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases. Biol Chem 384: 863-872. (Pubitemid 36874500)
6. Camphausen K, Moses MA, Beecken WD, Khan MK, Folkman J, O'Reilly MS. (2001). Radiation therapy to a primary tumor accelerates metastatic growth in mice. Cancer Res 61: 2207-2211. (Pubitemid 32692049)
7. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T. (2003). Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 253: 269-285.
8. Chen X, Su Y, Fingleton B, Acuff H, Matrisian LM, Zent R et al. (2005). Increased plasma MMP9 in integrin a1-null mice enhances lung metastasis of colon carcinoma cells. Int J Cancer 116: 52-61. (Pubitemid 40827754)
9. Cheng JC, Chou CH, Kuo ML, Hsieh CY. (2006). Radiationenhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway. Oncogene 25: 7009-7018. (Pubitemid 44722069)
10. Coussens LM, Tinkle CL, Hanahan D, Werb Z. (2000). MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103: 481-490.
11. Dong Z, Kumar R, Yang X, Fidler IJ. (1997). Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoM.A. Cell 88: 801-810. (Pubitemid 27164268)
12. Giraudo E, Inoue M, Hanahan D. (2004). An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J Clin Invest 114: 623-633. (Pubitemid 39578752)
13. Gnant M, Mlineritsch B, Schippinger W, Luschin-Ebengreuth G, Pöstlberger S, Menzel C et al. (2009). Endocrine therapy plus zoledronic acid in premenopausal breast cancer. N Engl J Med 360: 679-691.
14. Hartford AC, Gohongi T, Fukumura D, Jain RK. (2000). Irradiation of a primary tumor, unlike surgical removal, enhances angiogenesis suppression at a distal site: potential role of host-tumor interaction. Cancer Res 60: 2128-2131. (Pubitemid 30225172)
15. Hiratsuka S, Nakamura K, Iwai S, Murakami M, Itoh T, Kijima H et al. (2002). MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2: 289-300. (Pubitemid 41043963)
16. Huang S, Van Arsdall M, Tedjarati S, McCarty M, Wu W, Langley R et al. (2002). Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J Natl Cancer Inst 94: 1134-1142. (Pubitemid 34919050)
17. Jodele S, Chantrain CF, Blavier L, Lutzko C, Crooks GM, Shimada H et al. (2005). The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent. Cancer Res 65: 3200-3208. (Pubitemid 40524602)
18. Leeman MF, Curran S, Murray GI. (2003). New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression. J Pathol 201: 528-534. (Pubitemid 38256401)
19. Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH et al. (1999). The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors. Bioorg Med Chem Lett 9: 2887-2992.
20. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, MosesM et al. (1994). Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by Lewis lung carcinoM.A. Cell 79: 315-328. (Pubitemid 24324921)
21. Osinsky SP, Ganusevich II, Bubnorskaya LN, Valkovskaya NV, Kovelskaya AV, Sergienko TK et al. (2005). Hypoxia level and matrix metalloproteinases-2 and-9 activity in Lewis lung carcinoma: correlation with metastasis. Exp Oncol 27: 202-205. (Pubitemid 41585958)
22. Owen JL, Iragavarapu-Charyulu V, Gunja-Smith Z, Herbert LM, Grosso JF, Lopez DM. (2003). Up-regulation of matrix metalloproteinase-9 in T lymphocytes of mammary tumor bearers: role of vascular endothelial growth factor. J Immunol 171: 4340-4351. (Pubitemid 37238712)
23. Pozzi A, LeVine WF, Gardner HA. (2002). Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis. Oncogene 21: 272-281. (Pubitemid 34102135)
24. Rundhaug JE. (2005). Matrix metalloproteinases and angiogenesis. J Cell Mol Med 9: 267-285.
25. Thwin MM, Douni E, Arjunan P, Kollias G, Kumar PV, Gopalakrishnakone P. (2009). Suppressive effect of secretory phospholipase A2 inhibitory peptide on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts, and its antiarthritic activity in hTNFtg mice. Arthritis Res Ther 11: R138.
26. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV et al. (1999). Estimating kinetic parameters from dynamic contrastenhanced T1-weighted MRI of a diffusible tracer: standardized quantities and symbols. J Magn Reson Imag 10: 223-232. (Pubitemid 29463104)
27. Tofts PS, Kermode A. (1991). Measurement of the blood-brain barrier and leakage space using dynamic MR imaging 1. Fundamental concepts. Magn Reson Med 17: 357-367.
28. Vihinen P, Ala-aho R, Kahari V-M. (2005). Matrix metalloproteinases as therapeutic targets in cancer. Curr Cancer Drug Targets 5: 203-220. (Pubitemid 40694861)
29. Zhang Q, Furukawa K, Chen HH, Sakakibara T, Urano T, Furukawa K. (2006). Metastatic potential of mouse Lewis lung cancer cells is regulated via ganglioside GM1 by modulating the matrix metalloprotease-9 localization in lipid rafts. J Biol Chem 281: 18145-18155. (Pubitemid 44035614)